Conference Coverage

VIDEO: Device detects more atrial fibrillation, but when is intervention necessary?


 

AT THE INTERNATIONAL STROKE CONFERENCE

SAN DIEGO – After 6 months, Medtronic’s Reveal XT implant picked up atrial fibrillation in 8.6% of cryptogenic stroke patients. Standard monitoring found it in 1.4%, according to company data presented at the International Stroke Conference. Devices from Medtronic and other companies are going to make detection of asymptomatic atrial fibrillation more common, raising questions about when to intervene. Cardiologist Rod Passman, an investigator for the company, and neurologist Steven Greenberg shared their thoughts on the issue.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Genotyping adds little to optimized warfarin dosing
MDedge Family Medicine
Low event rates with real-world use of rivaroxaban in NOAC
MDedge Family Medicine
CRT shown highly cost effective in mild heart failure
MDedge Family Medicine
FDA panel rejects rivaroxaban again for acute coronary syndrome
MDedge Family Medicine
Personalization keys vision of improved atrial fib care
MDedge Family Medicine
Cooling the resuscitated sudden dead
MDedge Family Medicine
CoreValve holds size advantage for U.S. TAVR
MDedge Family Medicine
New tools for stroke prediction in atrial fibrillation
MDedge Family Medicine
Ablation edges out drugs for treatment-naive paroxysmal atrial fibrillation
MDedge Family Medicine
Continuous AF monitors raise questions about when to intervene
MDedge Family Medicine

Related Articles